Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues product defect alert
The recall affects the 400mg/ml containers of batch 20K091 with the expiry date of October 2022.
Recall affects batch of Revozyn RTU 400 mg/ml Suspension for Injection for Cattle.

The Veterinary Medicines Directorate (VMD) has issued a product defect alert for a single batch of Revozyn RTU 400 mg/ml Suspension for Injection for Cattle.

The recall affects the 400mg/ml containers of batch 20K091 with the expiry date of October 2022.

The VMD writes: ‘We wish to make wholesalers and veterinary surgeons aware that Eurovet Animal Health BV has initiated a Class II recall of Revozyn RTU 400 mg/ml Suspension for Injection for Cattle.

‘This recall is due to confirmed out of specification particle size distribution (the percentage of particles greater than 50 µm exceeds the specification) and out of specification redispersion time.’

The manufacturer, Eurovet Animal Health BV, is contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.